Business Description
T2 Biosystems Inc
NAICS : 325413
SIC : 2835
ISIN : US89853L3024
Description
Financial Strength
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.32 | |||||
Equity-to-Asset | -0.81 | |||||
Debt-to-Equity | -1.77 | |||||
Debt-to-EBITDA | -1.13 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -28.3 | |||||
Beneish M-Score | -3.79 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -84.6 | |||||
3-Year EBITDA Growth Rate | 78 | |||||
3-Year EPS without NRI Growth Rate | 78.2 | |||||
3-Year FCF Growth Rate | 78.4 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 2.29 | |||||
9-Day RSI | 1.69 | |||||
14-Day RSI | 1.5 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.45 | |||||
Quick Ratio | 0.36 | |||||
Cash Ratio | 0.28 | |||||
Days Inventory | 107.66 | |||||
Days Sales Outstanding | 75.04 | |||||
Days Payable | 44.08 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -39.9 | |||||
Shareholder Yield % | -147.72 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | -113.58 | |||||
Operating Margin % | -655.54 | |||||
Net Margin % | -696.19 | |||||
FCF Margin % | -671.88 | |||||
ROA % | -137.37 | |||||
ROIC % | -109.13 | |||||
ROC (Joel Greenblatt) % | -383.98 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 0.2 | |||||
EV-to-EBIT | -1.49 | |||||
EV-to-Forward-EBIT | -1.9 | |||||
EV-to-EBITDA | -1.52 | |||||
EV-to-Revenue | 9.25 | |||||
EV-to-Forward-Revenue | 6.34 | |||||
EV-to-FCF | -1.38 | |||||
Earnings Yield (Greenblatt) % | -67.11 | |||||
FCF Yield % | -147.75 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
T2 Biosystems Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 7.193 | ||
EPS (TTM) ($) | -145.998 | ||
Beta | -0.64 | ||
Volatility % | 96.78 | ||
14-Day RSI | 1.5 | ||
14-Day ATR ($) | 5.507216 | ||
20-Day SMA ($) | 78.949754 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range ($) | 2.82 - 104.2 | ||
Shares Outstanding (Mil) | 8.79 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
T2 Biosystems Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
T2 Biosystems Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
T2 Biosystems Inc Frequently Asked Questions
What is T2 Biosystems Inc(LTS:0A57)'s stock price today?
When is next earnings date of T2 Biosystems Inc(LTS:0A57)?
Does T2 Biosystems Inc(LTS:0A57) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |